“Transcriptomic Profiling and In Silico Drug Repurposing Reveal BIRC5 and AURKA as Actionable Targets in Triple-Negative Breast Cancer”, Bangla J Med Phys, vol. 16, no. 2, pp. 56–64, Dec. 2025, doi: 10.3329/bjmp.v16i2.84807.